JULIO EDUARDO
NUÑEZ VILLOTA
TITULAR DE UNIVERSIDAD
Institute of Clinical and Experimental Medicine
Praga, República ChecaPublicaciones en colaboración con investigadores/as de Institute of Clinical and Experimental Medicine (4)
2024
-
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes
New England Journal of Medicine, Vol. 390, Núm. 15, pp. 1394-1407
-
Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials
The Lancet, Vol. 403, Núm. 10437, pp. 1635-1648
2023
-
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial
Nature Medicine, Vol. 29, Núm. 9, pp. 2358-2365
-
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.
New England Journal of Medicine, Vol. 389, Núm. 12, pp. 1069-1084